Radiation arteriopathy in the transgenic arteriovenous fistula model

Authors

Michael T. Lawton, University of California, San FranciscoFollow
Christine M. Arnold, University of California, San Francisco
Yung J. Kim, University of California, San Francisco
Ernesto A. Bogarin, University of California, San Francisco
Campbell L. Stewart, University of California, San Francisco
Amanda A. Wulfstat, University of California, San Francisco
Nikita Derugin, University of California, San Francisco
Dennis Deen, University of California, San Francisco
William L. Young, University of California, San Francisco

Document Type

Article

Abstract

Objective: The transgenic arteriovenous fistula model, surgically constructed with transgenic mouse aorta interposed in common carotid artery-to-external jugular vein fistulae in nude rats, has a 4-month experimental window because patency and transgenic phenotype are lost over time. We adapted this model to investigate occlusive arteriopathy in brain arteriovenous malformations after radiosurgery by radiating grafted aorta before insertion in the fistula. We hypothesized that high-dose radiation would reproduce the arteriopathy observed clinically within the experimental time window and that deletions of endoglin (ENG) and endothelial nitric oxide synthase (eNOS) genes would modify the radiation response. METHODS: Radiation arteriopathy in the common carotid arteries of 171 wild-type mice was examined with doses of 25, 80, 120, or 200 Gy (Experiment 1). Radiation arteriopathy in 68 wild-type arteriovenous fistulae was examined histologically and morphometrically with preoperative radiation doses of 0, 25, or 200 Gy (Experiment 2). Radiation arteriopathy in 51 transgenic arteriovenous fistulae (36 ENG and 15 eNOS knock-out fistulae) was examined using preoperative radiation doses of 0, 25, or 200 Gy (Experiment 3). RESULTS: High-dose radiation (200 Gy) of mouse common carotid arteries induced only mild arteriopathy (mean score, 0.66) without intimal hyperplasia and with high mortality (68%). Radiation arteriopathy in wild-type arteriovenous fistulae was severe (mean score, 3.5 at 200 Gy), with intimal hyperplasia and medial disruption at 3 months, decreasing luminal areas with increasing dose, and no mortality. Arteriopathy was robust in transgenic arteriovenous fistulae with ENG +/- and with eNOS +/-, with thick intimal hyperplasia in the former and distinct smooth muscle cell proliferation in the latter. CONCLUSION: The transgenic arteriovenous fistula model can be adapted to rapidly reproduce radiation arteriopathy observed in resected brain arteriovenous malformations after radiosurgery. High radiation doses accelerate the progression of arteriopathy to fit the 4-month time limitation of the model, allowing transgenic tissues to retain their phenotypes throughout the experimental window. Modified radiation responses in ENG and eNOS knock-out fistulae indicate that arteriopathy after arteriovenous malformation radiosurgery might potentially be enhanced by altered gene expression.

Publication Date

5-1-2008

Publication Title

Neurosurgery

ISSN

0148396X

Volume

62

Issue

5

First Page

1129

Last Page

1138

PubMed ID

18580811

Digital Object Identifier (DOI)

10.1227/01.neu.0000325875.82999.3c

Recommended Citation

Lawton, Michael T.; Arnold, Christine M.; Kim, Yung J.; Bogarin, Ernesto A.; Stewart, Campbell L.; Wulfstat, Amanda A.; Derugin, Nikita; Deen, Dennis; and Young, William L., "Radiation arteriopathy in the transgenic arteriovenous fistula model" (2008). Neurosurgery. 965.
https://scholar.barrowneuro.org/neurosurgery/965